None listed
Conditions
Brief summary
Asthma outcomes are poor, despite effective medications. Patients are often satisfied with their asthma despite poor control; this satisfaction with their level of control is reported to their GP, and therefore there is often no driver towards an increase in medication. Asthma control assessment by GPs is currently subjective; GPs are more likely to recognise the need to change treatment if they use an objective measure The Asthma Control Test (ACT) score is a simple, objective measure of asthma control, not commonly used by New Zealand GPs ACT scores of less than or equal to 19 reflect poorly controlled asthma and scores greater than or equal to 20 reflect controlled asthma. The aim of the study is to see if a simple asthma "Step-Up" regime based on the objective ACT Score improves asthma outcomes
Interventions
Use of the ACT (Asthma Control Test) to guide an increase in asthma therapy. If ACT score is below 20, treatment is increased for 3 months. Treatment is in the form of asthma inhalers, and the investigators have discretion as to which drugs/doses are used
Sponsors
GlaxoSmithKline
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
16 Years to 55 Years
Healthy volunteers
No
Inclusion criteria
Doctor diagnosis of asthma Aged 16-55 ACT score of less than or equal to 19 out of 25 Prescription of a short acting bronchodilator, or an inhaled corticosteroid (ICS) plus short acting bronchodilator
Exclusion criteria
Treatment with long acting beta agonist (LABA) A diagnosis of COPD, bronchiectasis or pulmonary fibrosis Any other safety concern at the Investigator’s discretion Inability to understand the study requirements and/or give informed consent to participate
Outcome results
None listed